---
title: Rapid and High Throughput Octet® BLI Applications in Early Monoclonal Antibody Discovery
description: Insights into how Charles River Laboratories incorporates Octet® Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow.
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![Sartorius webinar landing page banner\_web](https://info.edifydigitalmedia.com/hubfs/Sartorius%20webinar%20landing%20page%20banner_web.jpg "Sartorius webinar landing page banner_web")

Rapid and High Throughput Octet® BLI Applications in Early Monoclonal Antibody Discovery

 

 

 

![DDW\_Charles River\_Logo\_2\_web](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW_Charles%20River_Logo_2_web.jpg?width=400&name=DDW_Charles%20River_Logo_2_web.jpg)

---

 

![Christina\_Pettus\_speaker\_image\_200px](https://info.edifydigitalmedia.com/hubfs/Christina_Pettus_speaker_image_200px.jpg "Christina_Pettus_speaker_image_200px")

Charles River, Antibody Discovery group, has integrated computational immunology, antibody engineering and phage display technologies into its comprehensive antibody discovery platforms that rapidly deliver antibody hits or optimised variants with a range of affinities, cross-species coverage, and improved drug-like characteristics. Charles River uses label-free biosensors and other bioanalytical assays to support biochemical/biophysical characterisation of biotherapeutic molecules including antibodies.

In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet® Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow for discovery campaigns, antibody optimisation, and IgG characterisation. The webinar elaborates on the use of the Octet® BLI for quality control of proteins, high throughput hit screening with crude single chain library clones and kinetic determination of antibody-antigen binding.

Key Learning Objectives from this webinar:

- Use of the Octet® BLI platform for ultrahigh throughput hit screening and for off-rate ranking of crude periplasmic extract samples during early antibody discovery.
- Octet® BLI applications in reagent quality control including binding interaction studies.

### Watch the Webinar

## Copyright 2022 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions